{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:49:16Z","timestamp":1761540556361},"reference-count":60,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.thromres.2004.06.026","type":"journal-article","created":{"date-parts":[[2004,7,30]],"date-time":"2004-07-30T05:36:44Z","timestamp":1091165804000},"page":"501-507","source":"Crossref","is-referenced-by-count":37,"title":["Coronary and valvular syndromes and antiphospholipid antibodies"],"prefix":"10.1016","volume":"114","author":[{"given":"Ricard","family":"Cervera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2004.06.026_bib1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.thromres.2004.06.026_bib2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis","volume":"96","author":"Petri","year":"1994","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2004.06.026_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1053\/sarh.2001.23498","article-title":"Coronary artery disease in systemic lupus erythematosus: a review of the literature","volume":"30","author":"Karrar","year":"2001","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.thromres.2004.06.026_bib4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.84.2.920","article-title":"Antiphospholipid antibodies and the heart. Lessons and pitfalls for the cardiologist","volume":"84","author":"Asherson","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2004.06.026_bib5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1191\/096120300678828226","article-title":"Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort","volume":"9","author":"Petri","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2004.06.026_bib6","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/art.1780291019","article-title":"Myocardial infarction in SLE and \u2018lupus-like\u2019 disease","volume":"29","author":"Asherson","year":"1985","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.thromres.2004.06.026_bib7","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.thromres.2004.06.026_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.CIR.91.1.23","article-title":"Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men","volume":"91","author":"Vaarala","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2004.06.026_bib9","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1001\/archinte.154.22.2605","article-title":"Antibodies to oxidized low-density lipoprotein predicting myocardial infarction","volume":"154","author":"Puurunen","year":"1994","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2004.06.026_bib10","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/blood.V90.10.3931","article-title":"Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies","volume":"90","author":"Iuliano","year":"1997","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2004.06.026_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/096120339800700229","article-title":"Antiphospholipid antibodies and myocardial infarction","volume":"7","author":"Vaarala","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2004.06.026_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0140-6736(86)92258-0","article-title":"Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events","volume":"1","author":"Hamsten","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2004.06.026_bib13","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1161\/01.STR.28.9.1660","article-title":"IgG anticardiolipin antibody titer >40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study","volume":"28","author":"Levine","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2004.06.026_bib14","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/096120339500400413","article-title":"The presence of antiphospholipid antibodies in acute myocardial infarction","volume":"4","author":"Adler","year":"1995","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2004.06.026_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0002-9343(96)00226-4","article-title":"Anticardiolipin antibodies and acute myocardial infarction in non-systemic lupus erythematosus patients: a controlled prospective study","volume":"171","author":"Zuckerman","year":"1996","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2004.06.026_bib16","series-title":"The antiphospholipid syndrome II-autoimmune thrombosis","first-page":"169","article-title":"Cardiac and pulmonary manifestations in the antiphospholipid syndrome","author":"Espinosa","year":"2002"},{"key":"10.1016\/j.thromres.2004.06.026_bib17","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1161\/01.ATV.17.11.3159","article-title":"Antibodies against cardiolipin and oxidatively modified LDL in 50-year old men predict myocardial infarction","volume":"17","author":"Wu","year":"1997","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.thromres.2004.06.026_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0140-6736(92)91057-F","article-title":"Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and non-haemorrhagic stroke","volume":"339","author":"Sletnes","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2004.06.026_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/hrt.69.5.391","article-title":"Anticardiolipin antibodies in ischaemic heart disease: marker or myth?","volume":"69","author":"Phadke","year":"1993","journal-title":"Br. Heart J."},{"key":"10.1016\/j.thromres.2004.06.026_bib20","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.CIR.102.11.1258","article-title":"Anticardiolipin antibodies and recurrent coronary events. A prospective study of 1150 patients","volume":"102","author":"Bili","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2004.06.026_bib21","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/0002-9149(90)91439-D","article-title":"Prevalence of anticardiolipin antibodies in coronary artery disease","volume":"65","author":"De Caterina","year":"1989","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2004.06.026_bib22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/096120339600500522","article-title":"Antiphospholipid antibodies and atherosclerosis","volume":"5","author":"Vaarala","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2004.06.026_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2007-1001887","article-title":"Antiphospholipid antibodies in coronary artery disease: a review","volume":"20","author":"Baker","year":"1994","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2004.06.026_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/hrt.79.1.96","article-title":"Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA","volume":"79","author":"Takeuchi","year":"1998","journal-title":"Heart"},{"key":"10.1016\/j.thromres.2004.06.026_bib25","first-page":"383","article-title":"Anticuerpos antifosfol\u00edpido y angor","volume":"7","author":"Fern\u00e1ndez Ballesteros","year":"1990","journal-title":"An. Med. Intern. (Madrid)"},{"key":"10.1016\/j.thromres.2004.06.026_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000176429","article-title":"Anticardiolipin antibodies in patients with unstable angina","volume":"84","author":"D\u00edaz","year":"1994","journal-title":"Cardiology"},{"key":"10.1016\/j.thromres.2004.06.026_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/08916939908994766","article-title":"High prevalence of anti-beta2-glycoprotein I antibodies in patients with ischemic heart disease","volume":"30","author":"Farsi","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.thromres.2004.06.026_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-2007-993293","article-title":"Coagulation abnormalities in patients with precocious coronary artery thrombosis and patients failing coronary artery bypass grafting and percutaneous transcoronary angioplasty","volume":"19","author":"Bick","year":"1993","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2004.06.026_bib29","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(87)91470-X","article-title":"Anticardiolipin antibodies and occlusion of coronary bypass grafts","volume":"2","author":"Gavaghan","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2004.06.026_bib30","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S0140-6736(86)92004-0","article-title":"Coronary artery bypass graft failure: an autoimmune phenomenon?","volume":"2","author":"Morton","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2004.06.026_bib31","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/0002-9149(92)91216-Q","article-title":"Increased IgM anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty","volume":"69","author":"Eber","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2004.06.026_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0002-8703(96)90409-3","article-title":"Multiple early percutaneous transluminal coronary angioplasty failures related to lupus anticoagulant","volume":"132","author":"Chambers","year":"1996","journal-title":"Am. Heart J."},{"key":"10.1016\/j.thromres.2004.06.026_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/08916939809003861","article-title":"Antiphospholipid antibodies: a new risk factor for restenosis after percutaneous transluminal coronary angioplasty?","volume":"27","author":"Ludia","year":"1998","journal-title":"Autoimmunity"},{"key":"10.1016\/j.thromres.2004.06.026_bib34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/00001721-199811000-00005","article-title":"Successful coronary stent implantation in a patient with primary antiphospholipid syndrome","volume":"9","author":"Jankowski","year":"1998","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.thromres.2004.06.026_bib35","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0167-5273(99)00096-0","article-title":"Recurrent acute coronary events in a patient with primary antiphospholipid syndrome: successful management with intracoronary stenting","volume":"71","author":"Umesan","year":"1999","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2004.06.026_bib36","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/0140-6736(90)91373-I","article-title":"Association of antibodies against phospholipids with heart valve disease in systemic lupus erythematosus","volume":"335","author":"Khamashta","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2004.06.026_bib37","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.82.2.369","article-title":"Cardiac abnormalities in systemic lupus erythematosus: association with raised anticardiolipin antibodies","volume":"82","author":"Nyhoyannopoulos","year":"1990","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2004.06.026_bib38","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/ard.51.2.156","article-title":"Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients","volume":"51","author":"Cervera","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2004.06.026_bib39","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0735-1097(92)90368-W","article-title":"Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies","volume":"20","author":"Roldan","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2004.06.026_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-116-4-293","article-title":"Valvular heart disease in the primary antiphospholipid syndrome","volume":"116","author":"Galve","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2004.06.026_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/096120339100100108","article-title":"High prevalence of significant heart valve lesions in patients with the \u2018primary\u2019 antiphospholipid syndrome","volume":"1","author":"Cervera","year":"1991","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2004.06.026_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0049-0172(97)80034-0","article-title":"Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment","volume":"27","author":"Nesher","year":"1997","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.thromres.2004.06.026_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","article-title":"Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients","volume":"96","author":"Vianna","year":"1994","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2004.06.026_bib44","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0735-1097(91)90749-Y","article-title":"Cardiac involvement in patients with primary antiphospholipid syndrome","volume":"18","author":"Brenner","year":"1991","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2004.06.026_bib45","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1191\/096120300678828532","article-title":"Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography","volume":"9","author":"Turiel","year":"2000","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2004.06.026_bib46","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0002-8703(99)70424-2","article-title":"Echocardiographic evaluation of patients with primary antiphospholipid syndrome","volume":"137","author":"Esp\u00ednola-Zavaleta","year":"1999","journal-title":"Am. Heart J."},{"key":"10.1016\/j.thromres.2004.06.026_bib47","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0894-7317(05)80034-3","article-title":"Transesophageal echocardiographic demonstration of resolution of mitral vegetations after warfarin in a patient with the primary antiphospholipid syndrome","volume":"8","author":"Skyrme-Jones","year":"1995","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.thromres.2004.06.026_bib48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0002-8703(94)90139-2","article-title":"Transesophageal echocardiographic detection of multiple valve masses in primary antiphospholipid syndrome with stroke","volume":"127","author":"Jafar","year":"1994","journal-title":"Am. Heart J."},{"key":"10.1016\/j.thromres.2004.06.026_bib49","unstructured":"P\u00e9rez-Villa F, Font J, Azqueta M, Par\u00e9 C, Cervera R, Reverter JC, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus. A prospective, long-term follow-up study. Ann Rheum Dis [in press]."},{"key":"10.1016\/j.thromres.2004.06.026_bib50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/096120339600500306","article-title":"Libman\u2013Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves","volume":"5","author":"Ziporen","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2004.06.026_bib51","first-page":"99","article-title":"Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease","volume":"17","author":"Amital","year":"1999","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.thromres.2004.06.026_bib52","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1191\/096120399678840873","article-title":"Increased endothelial cell expression of alpha3beta1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome","volume":"8","author":"Afek","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2004.06.026_bib53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/096120339600500111","article-title":"Valvular heart disease in primary antiphospholipid syndrome (PAPS): clinical and morphological findings","volume":"5","author":"Garc\u00eda-Torres","year":"1996","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2004.06.026_bib54","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/01.STR.16.3.512","article-title":"Multiple transient ischemic attacks, lupus anticoagulant and verrucous endocarditis","volume":"16","author":"D'Alton","year":"1985","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2004.06.026_bib55","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0002-9343(91)80009-B","article-title":"Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant","volume":"90","author":"Pope","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2004.06.026_bib56","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0894-7317(97)70050-6","article-title":"Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome","volume":"10","author":"Agirbasli","year":"1997","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.thromres.2004.06.026_bib57","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/archinte.155.3.325","article-title":"Dissolution of intracardiac mass lesions in the primary antiphospholipid syndrome","volume":"155","author":"O'Neill","year":"1995","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2004.06.026_bib58","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0735-1097(99)00024-8","article-title":"The presence of infection-related antiphospholipid antibodies in infective endocarditis determines a major risk factor for embolic events","volume":"33","author":"Kupferwasser","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2004.06.026_bib59","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/ard.47.11.947","article-title":"Diagnostic and therapeutic problems in two patients with antiphospholipid antibodies, heart valve lesions and transient ischaemic attacks","volume":"47","author":"Asherson","year":"1988","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2004.06.026_bib60","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/rheumatology\/30.4.305","article-title":"Haemodynamically significant non-infective verrucous endocarditis in a patient with \u2018primary\u2019 antiphospholipid syndrome","volume":"30","author":"Font","year":"1991","journal-title":"Br. J. Rheumatol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804003342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804003342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T22:11:34Z","timestamp":1585865494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384804003342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":60,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0049384804003342"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2004.06.026","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}